Suppression of NF-κB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 2, 1999, Pages 477-486

  Wang, Xiao Chun ^a   Jobin, Christian ^b   Allen, Janice B ^c   Roberts, Wendy L ^a   Jaffe, Glenn J ^a,d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN; PROTEASOME INHIBITOR; RANTES; TUMOR NECROSIS FACTOR ALPHA; ALPHA CHEMOKINE; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CHEMOTACTIC FACTOR; CXCL1 PROTEIN, HUMAN; CYSTEINE PROTEINASE INHIBITOR; CYTOKINE; GROWTH PROMOTOR; LEUPEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PRIMER DNA; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR RELA;

ARTICLE; CELLULAR DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CELL CULTURE; CHEMISTRY; DRUG COMBINATION; GENE EXPRESSION; GENETICS; METABOLISM; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CYSTEINE PROTEINASE INHIBITORS; CYTOKINES; DNA PRIMERS; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUPEPTINS; MACROPHAGE COLONY-STIMULATING FACTOR; NF-KAPPA B; PIGMENT EPITHELIUM OF EYE; RANTES; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

EID: 0032587384     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Limb GA, Little BC, Meager A, et al. Cytokines in proliferative vitreoretinopathy. Eye. 1991;5(pt 6):686-693.
2. Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease [Review]. Cytokine. 1992;4:1-5.
3. Einer SG, Einer VM, Bian ZM, et al. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products. Invest Ophthalmol Vis Sci. 1997; 38:446-455.
4. Einer SG, Einer VM, Pavilack MA, et al. Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest. 1992;66:200-211.
5. Einer SG, Strieter RM, Elner VM, Rollins BJ, Del Monte MA, Kunkel SL. Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest. 1991; 64:819-825.
6. Jaffe GJ, Peters WP, Roberts W, et al. Modulation of macrophage colony stimulating factor in cultured human retinal pigment epithelial cells. Exp Eye Res. 1992;54:595-603.
7. Jaffe GJ, Richmond A, Van Le L, et al. Expression of three forms of melanoma growth stimulating activity (MGSA)/gro in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1993;34: 2776-2785.
8. Jaffe GJ, Roberts WL, Wong HL, Yurochko AD, Cianciolo GJ. Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells. Exp Eye Res. 1995;60:533-543.
9. Planck SR, Huang XN, Robertson JE, Rosenbaum JT. Retinal pigment epithelial cells produce interleukin-1 beta and granulocyte-macrophage colony-stimulating factor in response to interleukin-1 alpha. Curr Eye Res. 1993;12:205-212.
10. Planck SR, Dang TT, Graves D, Tara D, Ansel JC, Rosenbaum JT. Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci. 1992;33:78-82.
11. Limb GA, Earley O, Jones SE, LeRoy F, Chignell AH, Dumonde DC. Expression of mRNA coding for TNF alpha, IL-1 beta and IL-6 by cells infiltrating retinal membranes. Graefes Arch Clin Exp Ophthalmol. 1994;232:646-651.
12. Limb GA, Alam A, Earley O, Green W, Chignell AH, Dumonde DC. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res. 1994;13:791-798.
13. Shattuck RL, Wood LD, Jaffe GJ, Richmond A. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells [published erratum appears in Mol Cell Biol. 1995 Feb;15:1136]. Mol Cell Biol. 1994;14:791-802.
14. Jaffe GJ, Van Le L, Valea F, et al. Expression of interleukin-1α, interleukin-1β, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res. 1992;55:325-335.
15. Baldwin A Jr. The NF-κB and IκB proteins: new discoveries and insights [Review]. Annu Rev Immunol. 1996;14:649-683.
16. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers [Review]. FASEB J. 1995;9:899-909.
17. Epstein FH. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med. 1997;336:1066-1071.
18. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996; 87:13-20.
19. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 1996;39:197-203.
20. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 1995;2:493-506.
21. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994;78:761-771.
22. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 1994;13:5433-5441.
23. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 1995;83:129-135.
24. Manni A, Kleimberg J, Ackerman V, Bellini A, Patalano F, Mattoli S. Inducibility of RANTES mRNA by IL-1β in human bronchial epithelial cells is associated with increased NF-κB DNA binding activity. Biochem Biophys Res Commun. 1996;220:120-124.
25. Rovin BH, Dickerson JA, Tan LC, Hebert CA. Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int. 1995;48:1263-1271.
26. Ueda A, Okuda K, Ohno S, et al. NF-kB and Sp1 regulate transcription of human monocyte chemoattractant protein gene. J Immunol. 1994;153:2052-2063.
27. Conner EM, Brand S, Davis JM, et al. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J Pharmacol Exp Ther. 1997;283:1.
28. Jaffe GJ, Earnest K, Fulcher S, Lui GM, Houston LL. Antitransferrin receptor immunotoxin inhibits proliferating human retinal pigment epithelial cells [see comments]. Arch Ophthalmol. 1990;108: 1163-1168.
29. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990;31:839-846.
30. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol. 1997;158:226-234.
31. Caldenhoven E, Liden J, Wissink S, et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of the glucocorticoids. Mol Endocrinol. 1995;9:401-412.
32. Stein B, Cogswell P, Baldwin A. Functional and physical associations between NF-κB and C/EBP family members: a Rel A domain-bZIP interaction. Mol Cell Biol. 1993;13:3964-3974.
33. Stein B, Baldwin A, Ballard D, Greene W, Angel P, Herrlich P. Cross coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 1993;12:3879-3891.
34. Jobin C, Hellerbrand C, Licato L, Brenner D, Sartor R. Mediation by NF-κB of cytokine induced expression of intercellular adhesin molecule 1 (ICAM-1) in an intestinal epithelial cell line a process blocked by proteasome inhibitors. Gut. 1998;42:779-787.
35. Hellerbrand C, Jobin C, Imuro Y, Licato L, Sartor R, Brenner D. Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super-repressor. Hepatology. 1998;27: 1285-1295.
36. Fleisher LN, Ferrell JB, McGahan MC. Synergistic uveitic effects of tumor necrosis factor-alpha and interleukin-1 beta. Invest Ophthalmol Vis Sci. 1992;33:2120-2127.
37. Nagineni CN, Detrick B, Hooks JJ. Synergistic effects of gamma interferon on inflammatory mediators that induce interleukin-6 gene expression and secretion by human retinal pigment epithelial cells. Clin Diagn Lab Immunol. 1994;1:569-577.
38. Jahnke A, Johnson JP. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and IFN-gamma is mediated by P65/p50 and p65/c-Rel and interferon-responsive factor Stat1alpha (91) that can be activated by both IFN-gamma and IFN-alpha. FEBS Lett. 1994;354:220-226.
39. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol. 1995;154:1870-1878.
40. Goebeler M, Yoshimura TT, Ritter U, Brocker E, Gillitzer R. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol. 1997;1997:445-451.